GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Eresearch Technology Inc. (ERT) [hlAlert]

Rating:
Buy ERES
up 38.40 %

Eresearch Technology Inc. (ERES) rated Buy with price target $8 by Auriga U.S.A

Posted on: Friday,  Feb 27, 2009  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy Eresearch Technology Inc. (NASDAQ: ERT) on 02/27/2009. Previously Auriga U.S.A rated Buy Eresearch Technology Inc. (NASDAQ: ERT) on
12/17/2008., when the stock price was $5.78. Since then, Eresearch Technology Inc. has gained 38.41% as of 07/02/2012's recent price of $8.00.
If you would have followed the previous Auriga U.S.A's recommendation on ERT, you would have gained 38.4% of your investment in 1293 days.

eResearchTechnology, Inc. (eRT) provides technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently. The Company offers centralized electrocardiographic (ECG) services (Cardiac Safety services or EXPeRT ECG services), which are used by pharmaceutical companies, biotechnology companies, medical device companies, clinical trial sponsors and clinical research organizations (CROs) during the conduct of clinical trials. It also offers site support, which includes the rental and sale of cardiac safety equipment along with related supplies and freight. The Company offers licensing and, at the client?s option, hosting of its EXPeRT eClinical software products and the provision of maintenance and consulting services in support of these products. Electronic patient reported outcomes (EXPeRT ePRO) services along with 57 clinical assessments are also offered.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/20/2010 8:25 AM Buy
None
7.12 9.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/27/2009 8:25 AM Buy
None
4.85 8.00
12/17/2008 8:25 AM Buy
None
5.78 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy